...
首页> 外文期刊>Journal of human genetics >Kagami-Ogata syndrome: a clinically recognizable upd (14)pat and related disorder affecting the chromosome 14q32.2 imprinted region
【24h】

Kagami-Ogata syndrome: a clinically recognizable upd (14)pat and related disorder affecting the chromosome 14q32.2 imprinted region

机译:Kagami-Ogata综合征:一种临床上可识别的upd(14)pat及其相关疾病,影响14q32.2染色体的印记区域

获取原文
获取原文并翻译 | 示例
           

摘要

Human chromosome 14q32.2 carries paternally expressed genes including DLK1 and RTL1, and maternally expressed genes including MEG3 and RTL1as, along with the germline-derived DLK1-MEG3 intergenic differentially methylated region (IG-DMR) and the postfertilization-derived MEG3-DMR. Consistent with this, paternal uniparental disomy 14 (upd(14) pat), and epimutations (hypermethylations) and microdeletions affecting the IG-DMR and/or the MEG3-DMR of maternal origin, result in a unique phenotype associated with characteristic face, a small bell-shaped thorax with coat-hanger appearance of the ribs, abdominal wall defects, placentomegaly and polyhydramnios. Recently, the name 'Kagami-Ogata syndrome' (KOS) has been approved for this clinically recognizable disorder. Here, we review the current knowledge about KOS. Important findings include the following: (1) the facial 'gestalt' and the increased coat-hanger angle constitute pathognomonic features from infancy through childhood/puberty; (2) the unmethylated IG-DMR and MEG3-DMR of maternal origin function as the imprinting control centers in the placenta and body respectively, with a hierarchical interaction regulated by the IG-DMR for the methylation pattern of the MEG3-DMR in the body; (3) RTL1 expression level becomes similar to 2.5 times increased in the absence of functional RTL1as-encoded microRNAs that act as a trans-acting repressor for RTL1; (4) excessive RTL1 expression and absent MEG expression constitute the primary underlying factor for the phenotypic development; and (5) upd(14) pat accounts for approximately two-thirds of KOS patients, and epimutations and microdeletions are identified with a similar frequency. Furthermore, we refer to diagnostic and therapeutic implications.
机译:人类染色体14q32.2携带父本表达的基因(包括DLK1和RTL1)以及母本表达的基因(包括MEG3和RTL1as),以及种系衍生的DLK1-MEG3基因间差异甲基化区域(IG-DMR)和受精后衍生的MEG3-DMR。与此相符的是,父系单亲二体性14(upd(14)pat)以及影响母体来源IG-DMR和/或MEG3-DMR的表位变异(超甲基化)和微缺失会导致与特征性面部相关的独特表型,小钟形的胸腔,肋骨有外套的外观,腹壁缺损,胎盘肥大和羊水过多。最近,已经为这种临床上可识别的疾病批准了名称“加贺-绪方综合症”(KOS)。在这里,我们回顾了有关KOS的最新知识。重要发现包括以下几个方面:(1)面部“姿势”和增加的衣架角度构成了从婴儿期到儿童期/青春期的病理特征。 (2)母体来源的未甲基化的IG-DMR和MEG3-DMR分别作为胎盘和体内的印记控制中心,并由IG-DMR调节体内MEG3-DMR的甲基化模式的层次相互作用; (3)在没有功能性RTL1as编码的microRNA充当RTL1的反式阻遏物的情况下,RTL1的表达水平增加了2.5倍; (4)过量的RTL1表达和缺少的MEG表达是表型发育的主要基础因素; (5)upd(14)拍子约占KOS患者的三分之二,并且以相似的频率识别出表位变异和微缺失。此外,我们指的是诊断和治疗意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号